What Is Erenumab, And How Can It Help Treat Migraines?

Migraines are more than just a minor headache. According to the World Health Organization, migraines affect over 1 billion people worldwide and can cause days of intense pain and disability. For many people, traditional treatments like pain medications simply don't work. That's why a revolutionary new drug, Erenumab, has been gaining attention in the medical community as a possible treatment option for this debilitating condition. In this article, we'll take a look at what Erenumab is, how it works, and how it can help treat migraines.

What is Erenumab?

Erenumab is a prescription medication used to treat migraines in adults. It is a monoclonal antibody that works by blocking the activity of a protein called calcitonin gene-related peptide (CGRP). CGRP is thought to play a role in migraine headaches. Erenumab is given as an injection under the skin once every 4 weeks.

Common side effects of erenumab include redness, pain, or itching at the injection site, nausea, and diarrhea. Erenumab can also cause serious allergic reactions. Tell your doctor if you have any signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.

Erenumab may interact with other medications. Erenumab is not recommended for use during pregnancy or breastfeeding.

How does Erenumab work?

Erenumab is a new type of migraine prevention medication. It is the first in a class of drugs called monoclonal antibodies. Monoclonal antibodies are created in a laboratory and are designed to target specific proteins in the body. Erenumab specifically targets and blocks the protein CGRP (calcitonin gene-related peptide). CGRP is thought to play a role in migraines and other types of headaches.

Erenumab is given as an injection once a month.Erenumab has been shown to be effective at reducing the number of migraine days per month in people who have migraines with and without aura. Aura is a visual or neurological symptom that can occur before or during a migraine headache.

What are the side effects of Erenumab?

The most common side effects of Erenumab are mild to moderate and include constipation, upper respiratory tract infection, and injection site reactions.

Headache is the most common side effect reported with Erenumab use. Other reported side effects include:

-Dizziness
-Fatigue
-Nausea
-Muscle pain

Rare but serious side effects of Erenumab include:

-Heart attack
-Stroke
-Allergic reactions

Who should take Erenumab?

If you suffer from chronic migraines – defined as migraines that occur on 15 or more days each month – you may be a candidate for erenumab. Erenumab is a new type of medication that works by blocking the activity of receptors for calcitonin gene-related peptide (CGRP). CGRP is involved in the transmission of pain signals associated with migraines, and by blocking its activity, erenumab can help to reduce the frequency and severity of migraine attacks.

Other potential candidates for erenumab include people who have tried other migraine treatments without success, as well as those who are unable to tolerate the side effects of other migraine medications. If you think you may be a candidate for erenumab.

How to use Erenumab

If you’re one of the many people who suffer from migraines, you know how debilitating they can be. And you’ve probably tried many different treatments in an effort to find relief. If you haven’t had much success with other treatments, you may be wondering if erenumab is right for you.

Erenumab is a new type of medication that’s been shown to be effective in treating migraines. It works by blocking a protein called CGRP, which plays a role in migraines. Erenumab is given as an injection once a month.

If you’re considering erenumab, They can help you weigh the risks and benefits of this medication and decide if it’s worth trying.

How is Erenumab administered?

Erenumab is a human monoclonal antibody that is administered as an injection. It is given as an subcutaneous injection once a month. The recommended dose is 70 mg for patients weighing 50 kg or less, and 140 mg for patients weighing more than 50 kg.

What are the success rates of Erenumab?

The success rates of Erenumab vary depending on the individual. However, clinical trials have shown that Erenumab can be effective in reducing the frequency of migraines in people who suffer from chronic migraines. In one study, patients who were given Erenumab saw a reduction in the number of days with migraines by about half. Patients who did not receive Erenumab saw no such reduction. These results suggest that Erenumab can be an effective treatment for migraines, though individual results may vary.

Are there any alternatives to Erenumab?

There are a few alternatives to erenumab. Botox is one alternative that can help prevent migraines by paralyzing overactive muscles in the head and neck. It is usually given every 12 weeks. Another alternative is topiramate, which is a seizure medication that can also help prevent migraines. It is typically taken daily. Lastly, magnesium supplements have also been shown to be effective in reducing migraine frequency and severity for some people.

Conclusion

Erenumab is an exciting new drug that shows great promise in treating the chronic pain and discomfort associated with migraine headaches. Although more research is needed to fully understand its potential benefits, the current findings suggest that this medication could be a game-changer for those suffering from migraines. 

Read more such content on @ Hidoc Dr | Medical Learning App for Doctors